Expert peer conversations on the future of radiopharmaceutical development — trial complexity, site readiness, patient identification, and the path to market, discussed by the people doing the work.
A moderated roundtable on the real-world considerations facing radiopharmaceutical programs, from trial design and operational complexity to the practical path forward for bringing these therapies to patients.
Bracken's consultants support radiopharmaceutical programs across strategy, clinical operations, imaging, and regulatory. If your program is navigating similar questions, we're glad to talk.
It's an ongoing conversation series that brings experienced peers together around the strategic, operational, clinical, and commercial questions shaping radiopharmaceutical development today — from trial complexity and site readiness to patient identification and market evolution. The format is candid and peer-to-peer: the people actually doing this work, comparing notes in the open.
Register through the pre-registration form. We'll send you the session details and joining information ahead of each roundtable.
Absolutely — and we hope you will. When you register, you can submit the questions and topics you most want explored. Each session's agenda is shaped in part by what attendees bring to it.
Recordings are available on demand on this page. Session 1, "When Trials Get Too Complex," is available now, with future sessions added here after they air.
Experienced peers from across the radiopharmaceutical field — bringing clinical, operational, regulatory, and commercial perspectives. It's built by peers, for peers: a candid, practical discussion grounded in real programs rather than a podium.
Subscribe to our monthly hand-crafted newsletter for the latest insights on clinical trial trends and the life science industry.
12 Penns Trail, Newtown, PA 18940
+1 215 648 1208
© 2026 the bracken group - Privacy Policy
12 Penns Trail, Newtown, PA 18940
+1 215 648 1208
© 2026 the bracken group - Privacy Policy
